Clinical trials
Phase 1/2 Epstein-Barr Virus Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 6 |
| Recruiting | 5 |
| Active, not recruiting | 3 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
| Suspended | 1 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atara Biotherapeutics | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| University of Minnesota | 2 |
| AlloVir | 1 |
| Baylor College of Medicine | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Cullinan Therapeutics Inc. | 1 |
| Daihong Liu | 1 |
| Dr. Jean-Sebastien Delisle, MD, PhD | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epstein-Barr Virus Infections | 31 |
| Adenoviridae Infections | 8 |
| Cytomegalovirus Infections | 7 |
| Infectious Mononucleosis | 4 |
| Nasopharyngeal Neoplasms | 4 |
| Virus Diseases | 4 |
| Infections | 3 |
| Lymphoma | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Neoplasms | 3 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.